KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 150 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $48,696,000 | +5.6% | 3,825,256 | +17.4% | 1.85% | -10.5% |
| Q4 2014 | $46,092,000 | -7.3% | 3,257,358 | -9.9% | 2.07% | -1.2% |
| Q3 2014 | $49,708,000 | -13.6% | 3,615,126 | -3.4% | 2.09% | -14.2% |
| Q2 2014 | $57,547,000 | -4.5% | 3,741,656 | +5.8% | 2.44% | -1.7% |
| Q1 2014 | $60,281,000 | +68.7% | 3,537,590 | +28.2% | 2.48% | +60.9% |
| Q4 2013 | $35,728,000 | – | 2,758,950 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |